138 related articles for article (PubMed ID: 25173589)
1. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
[TBL] [Abstract][Full Text] [Related]
2. PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells.
Morjen M; Kallech-Ziri O; Bazaa A; Othman H; Mabrouk K; Zouari-Kessentini R; Sanz L; Calvete JJ; Srairi-Abid N; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2013 Jan; 32(1):52-62. PubMed ID: 23262217
[TBL] [Abstract][Full Text] [Related]
3. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
4. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
[TBL] [Abstract][Full Text] [Related]
5. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
[TBL] [Abstract][Full Text] [Related]
6. Native and recombinant phospholipases A
Krayem N; Abdelkefi-Koubaa Z; Marrakchi N; Gargouri Y; Luis J
Int J Biol Macromol; 2018 Sep; 116():305-315. PubMed ID: 29715557
[TBL] [Abstract][Full Text] [Related]
7. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
[TBL] [Abstract][Full Text] [Related]
8. Expression of the First Recombinant Anti-Tumoral Snake Venom Kunitz-Type Serine Protease Inhibitor.
Morjen M; Moslah W; Touihri-Baraketi I; Srairi-Abid N; Luis J; Marrakchi N; Jebali J
Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324668
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki.
Lecht S; Chiaverelli RA; Gerstenhaber J; Calvete JJ; Lazarovici P; Casewell NR; Harrison R; Lelkes PI; Marcinkiewicz C
Biochim Biophys Acta; 2015 Jun; 1850(6):1169-79. PubMed ID: 25665484
[TBL] [Abstract][Full Text] [Related]
10. MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions.
Bazaa A; Pasquier E; Defilles C; Limam I; Kessentini-Zouari R; Kallech-Ziri O; El Battari A; Braguer D; El Ayeb M; Marrakchi N; Luis J
PLoS One; 2010 Apr; 5(4):e10124. PubMed ID: 20405031
[TBL] [Abstract][Full Text] [Related]
11. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis.
Chavakis T; Cines DB; Rhee JS; Liang OD; Schubert U; Hammes HP; Higazi AA; Nawroth PP; Preissner KT; Bdeir K
FASEB J; 2004 Aug; 18(11):1306-8. PubMed ID: 15208269
[TBL] [Abstract][Full Text] [Related]
12. Actions of the Kunitz-type serine protease inhibitor Amblyomin-X on VEGF-A-induced angiogenesis.
Drewes CC; Dias RY; Hebeda CB; Simons SM; Barreto SA; Ferreira JM; Chudzinski-Tavassi AM; Farsky SH
Toxicon; 2012 Sep; 60(3):333-40. PubMed ID: 22575283
[TBL] [Abstract][Full Text] [Related]
13. A novel integrin alpha5beta1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor.
Kim EY; Bang JY; Chang SI; Kang IC
Biochem Biophys Res Commun; 2008 Dec; 377(4):1288-93. PubMed ID: 18996355
[TBL] [Abstract][Full Text] [Related]
14. MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration.
Bazaa A; Luis J; Srairi-Abid N; Kallech-Ziri O; Kessentini-Zouari R; Defilles C; Lissitzky JC; El Ayeb M; Marrakchi N
Matrix Biol; 2009 May; 28(4):188-93. PubMed ID: 19351557
[TBL] [Abstract][Full Text] [Related]
15. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
[TBL] [Abstract][Full Text] [Related]
16. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
[TBL] [Abstract][Full Text] [Related]
17. Leberagin-C, A disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion.
Limam I; Bazaa A; Srairi-Abid N; Taboubi S; Jebali J; Zouari-Kessentini R; Kallech-Ziri O; Mejdoub H; Hammami A; El Ayeb M; Luis J; Marrakchi N
Matrix Biol; 2010 Mar; 29(2):117-26. PubMed ID: 19808093
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
19. Targeting α1 inserted domain (I) of α1β1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis.
Morjen M; Othman H; Abdelkafi-Koubaa Z; Messadi E; Jebali J; El Ayeb M; Abid NS; Luis J; Marrakchi N
Int J Biol Macromol; 2018 Oct; 117():790-799. PubMed ID: 29870815
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
Ren X; Dai M; Lin LP; Li PK; Ding J
Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
